Location: Home
  • search
  • go
  • Relate News
  • 12/13/2019Preview of 16 Heavy-weight New Drug Expected to be Approved in China N...
  • 12/13/2019IQVIA: Chinese Hospital Drug Market Up 9.7% in MAT Q3/2019
  • 12/12/2019Eli Lilly's Verzenio and Amgen's Blincyto To Be Granted Priority Revie...
  • 12/12/2019Astrazeneca Rounds Out Stellar China Year - And Beats Roche To The Pun...
  • 12/12/2019Numab and 3SBio's Subsidiary Form Partnership to Develop Novel Multi-s...
  • 12/12/2019AstraZeneca Granted Chinese Approval of Imfinziin for Unresectable Sta...
  • 12/11/2019Avantor Opens Center in Shanghai to Boost Biopharma Innovation in Chin...
  • 12/11/2019Harbin Pharmaceutical Group Poised to Take Over Ailing GNC
  • 12/10/2019National Drug Usage Monitoring Platform Becomes Operational
  • 12/10/2019SAMR Solicits Public Comments on the Provisions for Registration of Dr...
  • 12/10/2019China Cuts Prices For 70 More Drugs After Talks with Pharmaceutical Fi...
  • 12/9/2019PingAn Good Doctor and Merck Sign Agreement to Explore Integrated Heal...
  • 12/9/2019Samsung Bioepis Approved to Initiate Phase 3 Trial of Trastuzumab Bios...
  • 12/6/2019NHSA Issues New Policy for Drug Price Regulation
  • 12/6/2019Recent Executive Moves
  • 12/6/2019Innovent Announces First Patient Dosed in Phase I Trial of Anti-LAG-3 ...
  • 12/5/2019Amgen's IND for Osteoporosis Drug Romosozumab Approved in China
  • 12/5/2019XiAn Janssen's Application for 2nd Indication of Erleada Accepted in C...
  • 12/5/2019AstraZeneca-Merck Lynparza Approved in China for Ovarian Cancer
  • 12/4/2019Bio-Thera's IND for Biosimilar of Stelara (Ustekinumab) Approved in Ch...
  • 12/4/2019Additional Indication for Lenvima (Lenvatinib) For Differentiated Thyr...
  • 12/3/2019Why Chinese Biotech Companies Are Not For Faint-Hearted Investors
  • 12/3/2019New Round of Negotiation for NRDL Access Begins as Big Pharma Bosses L...
  • 12/3/2019Biotech Startup Alphamab to Raise $230M in HK IPO
  • 12/3/2019GI Innovation Out-licenses Immunotherapy Drug Candidate to Simcere Pha...
  • 12/2/2019State Council Issues New Centralized Drug Procurement Purchase and Use...
  • 12/2/2019NMPA Announces Withdrawal of Additional 68 Certificate Requirements to...
  • 11/29/2019Recent Executive Moves
  • 11/29/2019NMPA Approves Chipscreen's Chidamide (Epidaza) for Breast Cancer
  • 11/29/2019Hanmi's Chinese Partner to Start Trials for Anticancer Treatment
  • Page:140/370 Total number of articles:11096: [First][<<] [138] [139] [140] [141] [142] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group